Every trade that managers of Eisai Co., Ltd. disclose to EDINET (Japan FSA) is tracked on this page. The company is based in Tokyo, Japan. It was founded in 1936. 2 insiders have disclosed 5 filings since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (3,419 companies, median 3 filings), a count of 5 filings is above the norm.
No insider has bought Eisai Co., Ltd. shares on the open market in the past twelve months. Filings reach the EDINET (Japan FSA) feed a median of 6 days after the trade. That lag is the time during which only the insider knows about the trade.
This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
11 of 11 declarations
Eisai Co., Ltd. is a Japanese pharmaceutical company focused on the research and development of medications, particularly for neurological diseases. It is listed on the Tokyo Stock Exchange under the symbol XTKS.
Headquarters: Tokyo, Japan · Founded: 1936 · Wikipedia article
Source: Wikidata (CC0).